glp 1 vs semaglutide vs tirzepatide Tirzepatide, same medication class, different receptor targets. Here's what that actually means. Semaglutide targets the GLP-1 receptor, found in the brain, gut, and pancreas. targets two: GLP-1 and GIP Semaglutide vs Tirzepatide: Which GLP-1

Interestingly, these effects were more pronounced in the high-dose APLA group compared to PLA, suggesting dose- and type-dependent neurotoxicity (Qian et al., 2025)

Tivanisiran, a novel siRNA for the treatment of dry eye disease

Female participants showed slightly higher nausea rates (31% versus 24%), which is consistent with whats observed across other GLP-1 class compounds

Plasma glucose levels were measured using a glucometer, which has lower precision compared to laboratory-based plasma glucose measurements

Sodium Excretion: GLP-1 receptor agonism increases urinary sodium excretion

Sci Rep (2015) 5:14630.10.1038/srep14630 44 PalamaraATBrandiGRossiLMilloEBenattiUNencioniLet alNew synthetic glutathione derivatives with increased antiviral activities